Your browser doesn't support javascript.
loading
Effects of Lipid-Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE-3 Trial.
Dagenais, Gilles R; Jung, Hyejung; Lonn, Eva; Bogaty, Peter M; Dehghan, Mahshid; Held, Claes; Avezum, Alvaro; Jansky, Petr; Keltai, Matyàs; Leiter, Lawrence A; Lopez-Jaramillo, Patricio; Toff, William D; Bosch, Jackie; Yusuf, Salim.
Affiliation
  • Dagenais GR; Quebec Heart and Lung University Institute, Laval University, Quebec City, Quebec, Canada gilles.dagenais@criucpq.ulaval.ca.
  • Jung H; Population Health Research Institute, Hamilton General Hospital, McMaster University, Hamilton, Ontario, Canada.
  • Lonn E; Population Health Research Institute, Hamilton General Hospital, McMaster University, Hamilton, Ontario, Canada.
  • Bogaty PM; Quebec Heart and Lung University Institute, Laval University, Quebec City, Quebec, Canada.
  • Dehghan M; Population Health Research Institute, Hamilton General Hospital, McMaster University, Hamilton, Ontario, Canada.
  • Held C; Department of Medical Sciences, Cardiology, Uppsala Clinical Research Center, Uppsala, Sweden.
  • Avezum A; Dante Pazzanese Institute of Cardiology, University Santo Amaro, São Paulo, Brazil.
  • Jansky P; University Hospital Motol, Prague, Czech Republic.
  • Keltai M; Semmelweis University, Budapest, Hungary.
  • Leiter LA; Li Ka Shing Knowledge Institute, St. Michael's Hospital and Departments of Medicine and Nutritional Sciences, University of Toronto, Ontario, Canada.
  • Lopez-Jaramillo P; Research Department, FOSCAL, Medical School, University of Santander (UDES), Bucaramanga, Colombia.
  • Toff WD; Department of Cardiovascular Sciences, University of Leicester, and NIHR Leicester Biomedical Research Centre, Leicester, United Kingdom.
  • Bosch J; Population Health Research Institute, Hamilton General Hospital, McMaster University, Hamilton, Ontario, Canada.
  • Yusuf S; Population Health Research Institute, Hamilton General Hospital, McMaster University, Hamilton, Ontario, Canada.
J Am Heart Assoc ; 7(15)2018 07 22.
Article in En | MEDLINE | ID: mdl-30033433
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Primary Prevention / Tetrazoles / Benzimidazoles / Cardiovascular Diseases / Rosuvastatin Calcium / Healthy Lifestyle / Hydrochlorothiazide / Cholesterol, LDL Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Am Heart Assoc Year: 2018 Document type: Article Affiliation country: Canada Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Primary Prevention / Tetrazoles / Benzimidazoles / Cardiovascular Diseases / Rosuvastatin Calcium / Healthy Lifestyle / Hydrochlorothiazide / Cholesterol, LDL Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Am Heart Assoc Year: 2018 Document type: Article Affiliation country: Canada Country of publication: United kingdom